Publicacións nas que colabora con VICTORIA DIAZ TOME (23)

2024

  1. Development of inert coatings to prevent drug retention in 3D-printed diffusion cells

    International Journal of Pharmaceutics, Vol. 659

  2. Formulation strategies to improve the bioavailability of poorly absorbed drugs

    Dosage Forms, Formulation Developments and Regulations: Recent and Future Trends in Pharmaceutics, Volume 1, pp. 223-255

2023

  1. Antifungal Combination Eye Drops for Fungal Keratitis Treatment

    Pharmaceutics, Vol. 15, Núm. 1

  2. Desarrollo y estudio de formulaciones liposomales deciclopirox para administración ungueal

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps

    International Journal of Pharmaceutics, Vol. 635, pp. 122706

  4. Implantes intravítreos de PLGA cargados de dexametasona fabricados mediante espumado supercrítico

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  5. Intravitreal implants manufactured by supercritical foaming for treating retinal diseases

    Journal of Controlled Release, Vol. 362, pp. 342-355

  6. Partículas lipídicas nanoestructuradas para el tratamiento ocular del déficit de Cobalamina C (CblC) en niños

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 172, pp. 144-156

  2. Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery

    Pharmaceutics, Vol. 14, Núm. 4

2021

  1. Ciclodextrinas oftálmicas: Estudios de irritación y permanencia en la superficie ocular mediante Tomografía por Emisión de Positrones

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 143-145

  2. Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan/TPP and Chitosan/Sulfobutylether-β-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 3, pp. 3559-3575

  3. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  4. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 162, pp. 12-22

  5. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis

    International Journal of Pharmaceutics, Vol. 597

2020

  1. Biopharmaceutical assessment of dexamethasone acetate-based hydrogels combining hydroxypropyl cyclodextrins and polysaccharides for ocular delivery

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-19

  2. Drug delivery to the posterior segment of the eye: Biopharmaceutic and pharmacokinetic considerations

    Pharmaceutics, Vol. 12, Núm. 3

  3. Novel polymeric formulation for removal of gastrointestinal polyps by digestive endoscopy

    Pharmaceutics, Vol. 12, Núm. 4

2019

  1. Therapeutic approach in fungal keratitis

    Mycotic Keratitis (CRC Press), pp. 189-216

2018

  1. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis

    Journal of Pharmaceutical Sciences, Vol. 107, Núm. 5, pp. 1342-1351